Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Isradipine

BR, Inh 75695-93-1 Isopropyl methyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate, PN 200-110
Produktnummer ABIN1027903
268,21 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 7 bis 10 Werktagen

Kurzübersicht für Isradipine (ABIN1027903)

Applikation

Blocking Reagent (BR), Inhibition (Inh)

Chemical Name

Isopropyl methyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate, PN 200-110
  • Verwendungszweck

    L-type Ca channel blocker

    Produktmerkmale

    L-type Ca channel blocker.

    Reinheit

    >98 %

    Formel

    C19H21N3O5

    Löslichkeit

    Soluble to 50 mM in DMSO and to 20 mM in ethanol
  • Kommentare

    Source: Synthetic.
    Appearance: Yellow Crystalline Solid

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Solid

    Vorsichtsmaßnahmen

    Classification: Caution: Substance not yet fully tested. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection Hazard Phrases: H302-H315-H317-H318-H335 Precautionary Phrases: P261-P280-P305 + P351 + P338

    Handhabung

    Classification: Caution: Substance not yet fully tested. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection Hazard Phrases: H302-H315-H317-H318-H335 Precautionary Phrases: P261-P280-P305 + P351 + P338

    Lagerung

    -20 °C
  • Hintergrund

    Isradipine is a calcium channel blocker of the dihydropyridine class. It is usually used in the treatment of high blood pressure because of its anti-hypertensive properties in vivo. Recent studies suggest a potential use for Parkinson’s disease.
    Synonyms: PN 200-110

    Molekulargewicht

    371.39

    CAS-Nummer

    75695-93-1
Sie sind hier:
Chat with us!